Hbo1 Links p53-Dependent Stress Signaling to DNA Replication Licensing

ABSTRACT Hbo1 is a histone acetyltransferase (HAT) that is required for global histone H4 acetylation, steroid-dependent transcription, and chromatin loading of MCM2-7 during DNA replication licensing. It is the catalytic subunit of protein complexes that include ING and JADE proteins, growth regulatory factors and candidate tumor suppressors. These complexes are thought to act via tumor suppressor p53, but the molecular mechanisms and links between stress signaling and chromatin, are currently unknown. Here, we show that p53 physically interacts with Hbo1 and negatively regulates its HAT activity in vitro and in cells. Two physiological stresses that stabilize p53, hyperosmotic shock and DNA replication fork arrest, also inhibit Hbo1 HAT activity in a p53-dependent manner. Hyperosmotic stress during G1 phase specifically inhibits the loading of the MCM2-7 complex, providing an example of the chromatin output of this pathway. These results reveal a direct regulatory connection between p53-responsive stress signaling and Hbo1-dependent chromatin pathways.

[1]  R. Gibbons Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. , 2005, Human molecular genetics.

[2]  S. Berger,et al.  Repression of p53 activity by Smyd2-mediated methylation , 2006, Nature.

[3]  E. Milgrom,et al.  Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription. , 2006, Molecular endocrinology.

[4]  Colin Campbell,et al.  Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones , 2002, Genes, chromosomes & cancer.

[5]  S. Forsburg,et al.  Eukaryotic DNA replication in a chromatin context. , 2006, Current topics in developmental biology.

[6]  P. Muganda,et al.  Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts , 1994, Journal of virology.

[7]  Paul Tempst,et al.  Regulation of p53 activity through lysine methylation , 2004, Nature.

[8]  W. Herr,et al.  Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Grossman,et al.  Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.

[10]  K. Cimprich,et al.  A requirement for replication in activation of the ATR-dependent DNA damage checkpoint. , 2002, Genes & development.

[11]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[12]  M. Pacek,et al.  A requirement for MCM7 and Cdc45 in chromosome unwinding during eukaryotic DNA replication , 2004, The EMBO journal.

[13]  J. Nevins,et al.  Replication Factors MCM2 and ORC1 Interact with the Histone Acetyltransferase HBO1* , 2001, The Journal of Biological Chemistry.

[14]  S. Berger,et al.  Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. , 2001, Molecular cell.

[15]  L. Cox,et al.  A direct effect of activated human p53 on nuclear DNA replication. , 1995, The EMBO journal.

[16]  Y. Taya,et al.  Osmotic Shock Induces G1 Arrest through p53 Phosphorylation at Ser33 by Activated p38MAPK without Phosphorylation at Ser15 and Ser20 * , 2001, The Journal of Biological Chemistry.

[17]  K. Riabowol,et al.  Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. , 2006, Experimental cell research.

[18]  C. Hagemeier,et al.  Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin , 2003, EMBO reports.

[19]  R. Margolis,et al.  Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Ze-Guang Han,et al.  Nuclear localization signal of ING4 plays a key role in its binding to p53. , 2005, Biochemical and biophysical research communications.

[21]  C. Harris,et al.  p53: traffic cop at the crossroads of DNA repair and recombination , 2005, Nature Reviews Molecular Cell Biology.

[22]  G. Stark,et al.  p53 inhibits entry into mitosis when DNA synthesis is blocked , 1999, Oncogene.

[23]  B. Calvi,et al.  Chromatin regulates origin activity in Drosophila follicle cells , 2004, Nature.

[24]  Koh Miura,et al.  p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. , 2003, Cancer research.

[25]  E. Cho,et al.  p53 stabilization and transactivation by a von Hippel-Lindau protein. , 2006, Molecular cell.

[26]  A. Giaccia,et al.  The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality , 2005, Nature Genetics.

[27]  K. Mohammad,et al.  Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.

[28]  W. Deppert,et al.  Transcription-independent pro-apoptotic functions of p53. , 2005, Current opinion in cell biology.

[29]  Sue Biggins,et al.  Histone variants: deviants? , 2005, Genes & development.

[30]  S. Berger,et al.  CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. , 1997, Cancer research.

[31]  O. Gozani,et al.  The fellowships of the INGs , 2005, Journal of cellular biochemistry.

[32]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[33]  Song Tan,et al.  ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. , 2006, Molecular cell.

[34]  Yi Tang,et al.  Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. , 2006, Molecular cell.

[35]  K. Riabowol,et al.  Different HATS of the ING1 gene family. , 2002, Trends in cell biology.

[36]  J. Cook,et al.  Distinct Action of the Retinoblastoma Pathway on the DNA Replication Machinery Defines Specific Roles for Cyclin-Dependent Kinase Complexes in Prereplication Complex Assembly and S-Phase Progression , 2006, Molecular and Cellular Biology.

[37]  M. V. Panchenko,et al.  Jade-1, a candidate renal tumor suppressor that promotes apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Bruce Stillman,et al.  Chromatin Association of Human Origin Recognition Complex, Cdc6, and Minichromosome Maintenance Proteins during the Cell Cycle: Assembly of Prereplication Complexes in Late Mitosis , 2000, Molecular and Cellular Biology.

[39]  Wei Gu,et al.  Synergistic activation of transcription by CBP and p53 , 1997, Nature.

[40]  Bruce Stillman,et al.  Nucleosomal DNA regulates the core-histone-binding subunit of the human Hat1 acetyltransferase , 1998, Current Biology.

[41]  S. Berger,et al.  Histone modifications in transcriptional regulation. , 2002, Current opinion in genetics & development.

[42]  C. Prives,et al.  p53 accumulates but is functionally impaired when DNA synthesis is blocked. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  K. Struhl,et al.  Differential Gene Regulation by Selective Association of Transcriptional Coactivators and bZIP DNA-Binding Domains , 2006, Molecular and Cellular Biology.

[44]  Anindya Dutta,et al.  DNA replication in eukaryotic cells. , 2002, Annual review of biochemistry.

[45]  M. Fraga,et al.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.

[46]  H. Takisawa,et al.  Regulation of Replication Licensing by Acetyltransferase Hbo1 , 2006, Molecular and Cellular Biology.

[47]  B. Vogelstein,et al.  p53 functions as a cell cycle control protein in osteosarcomas , 1990, Molecular and cellular biology.

[48]  Zoi Lygerou,et al.  The Human Licensing Factor for DNA Replication Cdt1 Accumulates in G1 and Is Destabilized after Initiation of S-phase* , 2001, The Journal of Biological Chemistry.

[49]  J. Diffley,et al.  Uninterrupted MCM2-7 function required for DNA replication fork progression. , 2000, Science.

[50]  J. Timson Hydroxyurea. , 2020, Mutation research.

[51]  Z. Niu,et al.  Cyclin‐dependent kinase 11p58 interacts with HBO1 and enhances its histone acetyltransferase activity , 2005, FEBS letters.

[52]  M. Foiani,et al.  The DNA damage response during DNA replication. , 2005, Current opinion in cell biology.

[53]  Y. Taya,et al.  Requirement of clathrin heavy chain for p53-mediated transcription. , 2006, Genes & development.

[54]  G. Woude,et al.  Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.

[55]  D. Spector,et al.  Human Cytomegalovirus Infection Leads to Accumulation of Geminin and Inhibition of the Licensing of Cellular DNA Replication , 2003, Journal of Virology.

[56]  R. Margolis,et al.  Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phase stasis. , 2002, Journal of cell science.

[57]  S. Berger,et al.  p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.

[58]  Ronen Marmorstein,et al.  Acetylation of the p53 DNA-binding domain regulates apoptosis induction. , 2006, Molecular cell.

[59]  C. Disteche,et al.  The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein , 1996, Nature Genetics.

[60]  J. Nevins,et al.  Functional analysis of E2F transcription factor. , 1997, Methods in enzymology.

[61]  C. Prives,et al.  Replication of damaged DNA in vitro is blocked by p53. , 2003, Nucleic acids research.

[62]  D. Reinberg,et al.  ING 1 Candidate Tumor Suppressor p 33 Complex in Growth Regulation by the Role of the Sin 3-Histone Deacetylase , 2001 .

[63]  R. Poon,et al.  Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways. , 2006, Cancer research.

[64]  Sharon Y. R. Dent,et al.  Histone modifying enzymes and cancer: Going beyond histones , 2005, Journal of cellular biochemistry.

[65]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[66]  S. Berger,et al.  Crystal structure of yeast Esa1 suggests a unified mechanism for catalysis and substrate binding by histone acetyltransferases. , 2000, Molecular cell.

[67]  B. Lim,et al.  Androgen Receptor Interacts with a Novel MYST Protein, HBO1* , 2000, The Journal of Biological Chemistry.

[68]  R. Goodman,et al.  CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.

[69]  Takeshi Suzuki,et al.  New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.

[70]  B. Stillman,et al.  Histone Acetyltransferase HBO1 Interacts with the ORC1 Subunit of the Human Initiator Protein* , 1999, The Journal of Biological Chemistry.

[71]  Anindya Dutta,et al.  Right Place, Right Time, and Only Once: Replication Initiation in Metazoans , 2005, Cell.

[72]  J. Côté,et al.  The MYST family of histone acetyltransferases. , 2003, Current topics in microbiology and immunology.

[73]  M. Kitamura,et al.  Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.

[74]  Xiang-Jiao Yang The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. , 2004, Nucleic acids research.

[75]  N. Chabbert-Buffet,et al.  Ligand-controlled Interaction of HBO1 with the N-terminal Transactivating Domain of Progesterone Receptor Induces SRC-1-dependent Co-activation of Transcription , 2006 .

[76]  D. Notterman,et al.  Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity , 1998, Oncogene.

[77]  William Stedman,et al.  ORC, MCM, and Histone Hyperacetylation at the Kaposi's Sarcoma-Associated Herpesvirus Latent Replication Origin , 2004, Journal of Virology.

[78]  Y. Saintigny,et al.  p53's double life: transactivation-independent repression of homologous recombination. , 2004, Trends in genetics : TIG.